Quadrant Capital Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-474
| Closed | -$3.48K | – | 2843 |
|
|
2024
Q4 | $3.48K | Sell |
474
-2,852
| -86% | -$20.9K | ﹤0.01% | 2389 |
|
|
2024
Q3 | $24.9K | Sell |
3,326
-776
| -19% | -$5.81K | ﹤0.01% | 1805 |
|
|
2024
Q2 | $36.5K | Sell |
4,102
-2,637
| -39% | -$23.5K | ﹤0.01% | 1561 |
|
|
2024
Q1 | $68.3K | Buy |
6,739
+3,769
| +127% | +$38.2K | 0.01% | 1208 |
|
|
2023
Q4 | $29.9K | Buy |
2,970
+2,177
| +275% | +$21.9K | ﹤0.01% | 1638 |
|
|
2023
Q3 | $7.43K | Buy |
793
+192
| +32% | +$1.8K | ﹤0.01% | 2068 |
|
|
2023
Q2 | $14.7K | Sell |
601
-1,357
| -69% | -$33.3K | ﹤0.01% | 1860 |
|
|
2023
Q1 | $45.6K | Buy |
1,958
+1,403
| +253% | +$32.6K | ﹤0.01% | 1287 |
|
|
2022
Q4 | $14K | Sell |
555
-415
| -43% | -$10.5K | ﹤0.01% | 1811 |
|
|
2022
Q3 | $19K | Buy |
970
+575
| +146% | +$11.3K | ﹤0.01% | 1589 |
|
|
2022
Q2 | $10K | Buy |
395
+324
| +456% | +$8.2K | ﹤0.01% | 1683 |
|
|
2022
Q1 | $2K | Buy |
71
+38
| +115% | +$1.07K | ﹤0.01% | 2205 |
|
|
2021
Q4 | $1K | Sell |
33
-36
| -52% | -$1.09K | ﹤0.01% | 2422 |
|
|
2021
Q3 | $3K | Buy |
69
+64
| +1,280% | +$2.78K | ﹤0.01% | 2081 |
|
|
2021
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 2575 |
|